Skip to main content
Tempus AI, Inc (TEM)
NASDAQ: TEM · Real-Time Price · USD
35.54
+2.51 (7.60%)
At close: Dec 20, 2024, 4:00 PM
35.92
+0.38 (1.07%)
After-hours: Dec 20, 2024, 7:50 PM EST

Tempus AI Revenue

Tempus AI had revenue of $180.93M in the quarter ending September 30, 2024, with 32.98% growth. This brings the company's revenue in the last twelve months to $640.44M, up 32.13% year-over-year. In the year 2023, Tempus AI had annual revenue of $531.82M with 65.85% growth.

Revenue (ttm)
$640.44M
Revenue Growth
+32.13%
P/S Ratio
5.22
Revenue / Employee
$328,095
Employees
1,952
Market Cap
5.60B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023531.82M211.15M65.85%
Dec 31, 2022320.67M62.82M24.36%
Dec 31, 2021257.85M69.85M37.15%
Dec 31, 2020188.00M125.95M202.95%
Dec 31, 201962.06M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
RadNet 1.77B
Alkermes 1.51B
Inspire Medical Systems 755.59M
Corcept Therapeutics 628.56M
Telix Pharmaceuticals 430.80M
Krystal Biotech 241.52M
BridgeBio Pharma 217.77M
Cytokinetics 3.22M
Revenue Rankings

TEM News

More News